510(k) K852767
K852767 is an FDA 510(k) premarket notification submitted by Panmed, Inc. for the device "ERYTHOCYTE CREATINE". The FDA issued a decision of Substantially Equivalent on Nov 13, 1986. The device falls under product code JLA (Conversion To Creatinine, Creatine), a Class I device regulated under 21 CFR 862.1210. Panmed, Inc. has 15 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Nov 13, 1986
- Date Received
- Jun 28, 1985
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Conversion To Creatinine, Creatine
- Device Class
- Class I
- Regulation Number
- 862.1210
- Review Panel
- CH
- Submission Type
- 510(k) Exempt
Need the full FDA record for Panmed, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.